EXAS "Exact Sciences test detects 92 pct colorectal cancers"
April 18 | Thu Apr 18, 2013 6:56am EDT
(Reuters) - Exact Sciences Corp said its molecular screening test for colorectal cancer met the main goal of detecting the disease in more patients than other commonly used screening tests in a large late-stage study.
Exact's test, which identifies abnormal DNA in cells shed in a patient's stool, detected 92 percent of colorectal cancers and 42 percent of pre-cancerous polyps in a study on more than 10,000 people, the company said on Thursday.
The study compared the performance of the Cologuard test to colonoscopy and fecal immunochemical testing or FIT.
...and yet it's selling off in the premarket- guess I gotta find out where it's sucking...
Theo ;-)
